Clinical Trial: KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma)

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596693) titled 'KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma)' on May 13.

Brief Summary: This is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability and preliminary efficacy of KXV01 TCR Lentinvivo for patients with advanced solid tumors.

Study Start Date: Dec. 19, 2025

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: KXV01 TCR Lentinvivo Injection

KXV01 TCR Lentinvivo Injection is one kind of third-generation non-replicative self-inactivating lentivirus vector which carries an effective patient's personalized t...